Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-2002 | 07-2001 | 12-2000 | 07-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,016 | -2,501 | N/A | 1,301 | N/A |
| Depreciation Amortization | 194 | 215 | 50 | 209 | 50 |
| Accounts receivable | 1,604 | -362 | N/A | -694 | N/A |
| Other Working Capital | 1,067 | 1,216 | 1,330 | -322 | 780 |
| Other Operating Activity | -516 | 1,185 | 30 | -36 | 30 |
| Operating Cash Flow | $-1,666 | $-247 | $1,410 | $458 | $860 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 207 | N/A | -265 | N/A |
| PPE Investments | -31 | -28 | -10 | -31 | -10 |
| Purchase Of Investment | -100 | -100 | N/A | -698 | N/A |
| Other Investing Activity | -333 | -666 | -1,320 | 0 | -790 |
| Investing Cash Flow | $-464 | $-587 | $-1,330 | $-993 | $-800 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 21 | N/A | 1,620 | N/A |
| Common Stock Repurchased | N/A | -679 | N/A | -277 | N/A |
| Other Financing Activity | 0 | 0 | -360 | 0 | -10 |
| Financing Cash Flow | $N/A | $-658 | $-360 | $1,343 | $-10 |
| Beginning Cash Position | 5,018 | 1,716 | N/A | 909 | N/A |
| End Cash Position | 2,887 | 224 | N/A | 1,716 | N/A |
| Net Cash Flow | $-2,131 | $-1,492 | $-280 | $808 | $50 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,666 | -247 | 1,410 | 458 | 860 |
| Capital Expenditure | -31 | -28 | N/A | -31 | N/A |
| Free Cash Flow | -1,697 | -274 | 1,410 | 427 | 860 |